BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21525256)

  • 1. (n-3) long-chain PUFA differentially affect resistance to Pseudomonas aeruginosa infection of male and female cftr-/- mice.
    Tiesset H; Bernard H; Bartke N; Beermann C; Flachaire E; Desseyn JL; Gottrand F; Husson MO
    J Nutr; 2011 Jun; 141(6):1101-7. PubMed ID: 21525256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of fish oils on the outcomes of a mouse model of acute Pseudomonas aeruginosa pulmonary infection.
    Caron E; Desseyn JL; Sergent L; Bartke N; Husson MO; Duhamel A; Gottrand F
    Br J Nutr; 2015 Jan; 113(2):191-9. PubMed ID: 25564047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional effects on host response to lung infections with mucoid Pseudomonas aeruginosa in mice.
    van Heeckeren AM; Schluchter M; Xue L; Alvarez J; Freedman S; St George J; Davis PB
    Infect Immun; 2004 Mar; 72(3):1479-86. PubMed ID: 14977953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
    Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
    Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice.
    van Heeckeren AM; Schluchter MD; Drumm ML; Davis PB
    Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L944-52. PubMed ID: 15246977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection.
    Tiesset H; Pierre M; Desseyn JL; Guéry B; Beermann C; Galabert C; Gottrand F; Husson MO
    J Nutr; 2009 Jan; 139(1):82-9. PubMed ID: 19056659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
    Stotland PK; Radzioch D; Stevenson MM
    Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of CFTR and Mucoid Phenotype on Susceptibility and Innate Immune Responses in a Mouse Model of Pneumococcal Lung Disease.
    Dennis EA; Coats MT; Griffin SE; Hale JY; Novak L; Briles DE; Crain MJ
    PLoS One; 2015; 10(10):e0140335. PubMed ID: 26469863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection.
    Day BJ; van Heeckeren AM; Min E; Velsor LW
    Infect Immun; 2004 Apr; 72(4):2045-51. PubMed ID: 15039325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.
    Hunt WR; Zughaier SM; Guentert DE; Shenep MA; Koval M; McCarty NA; Hansen JM
    Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L43-9. PubMed ID: 24097557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection.
    Van Heeckeren AM; Scaria A; Schluchter MD; Ferkol TW; Wadsworth S; Davis PB
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L717-26. PubMed ID: 14514520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice.
    van Heeckeren AM; Schluchter MD; Xue W; Davis PB
    Am J Respir Crit Care Med; 2006 Feb; 173(3):288-96. PubMed ID: 16272448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.
    Palomo J; Marchiol T; Piotet J; Fauconnier L; Robinet M; Reverchon F; Le Bert M; Togbe D; Buijs-Offerman R; Stolarczyk M; Quesniaux VF; Scholte BJ; Ryffel B
    PLoS One; 2014; 9(12):e114884. PubMed ID: 25500839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linoleic acid supplementation results in increased arachidonic acid and eicosanoid production in CF airway cells and in cftr-/- transgenic mice.
    Zaman MM; Martin CR; Andersson C; Bhutta AQ; Cluette-Brown JE; Laposata M; Freedman SD
    Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L599-606. PubMed ID: 20656894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid.
    Freedman SD; Weinstein D; Blanco PG; Martinez-Clark P; Urman S; Zaman M; Morrow JD; Alvarez JG
    J Appl Physiol (1985); 2002 May; 92(5):2169-76. PubMed ID: 11960971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa.
    Gosselin D; Stevenson MM; Cowley EA; Griesenbach U; Eidelman DH; Boulé M; Tam MF; Kent G; Skamene E; Tsui LC; Radzioch D
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1253-62. PubMed ID: 9563748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
    Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
    J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice.
    van Heeckeren AM; Tscheikuna J; Walenga RW; Konstan MW; Davis PB; Erokwu B; Haxhiu MA; Ferkol TW
    Am J Respir Crit Care Med; 2000 Jan; 161(1):271-9. PubMed ID: 10619831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
    Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
    Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.